Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Acquity Group Currently Estimates IPO Price To Be $8.00-$10.00/ADS - Quick Facts

Digital advertiser Acquity Group Ltd. said it now estimates the initial public offering price to be between $8.00 and $10.00 per ADS. The company is offering 9.56 million of its ordinary shares in the form of ADSs and the selling shareholders named in the prospectus are selling 1.56 million ordinary shares in the form of ADSs.

Acquity Group noted that it will not receive any proceeds from the sale of the ADSs by the selling shareholders. The ADSs may be evidenced by American depositary receipts, or ADRs, and each ADS represents two ordinary shares, par value $0.0001 per ordinary share.

Acquity Group has applied to have the ADSs listed on the New York Stock Exchange, or the NYSE, under the symbol "AQ".

Click here to receive FREE breaking news email alerts for Acquity Group Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After recovering from an initial move to the downside, stocks have moved mostly higher over the course of the trading day on Tuesday. The major average have all turned positive, with the Nasdaq and the S&P 500 bouncing off their worst levels in almost a month. Senate Republicans once again voted Monday to block a Democratic bill aimed at narrowing the national gender wage gap. The Senate voted 52 to 40 in favor of limiting debate on the Paycheck Fairness Act, falling well short of the 60 votes required. After reporting a modest uptick in U.S. producer prices in the previous month, the Labor Department released a report on Tuesday showing that producer prices came in unchanged in the month of August. The Labor Department said its producer price index for final demand was unchanged in August after inching up by 0.1 percent in July.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.